Positron emission tomography (PET) imaging using the tracer \[^11^C\]DASB is a sensitive and noninvasive technique for measuring brain serotonin transporter (5-HTT) levels in vivo[@R1] . Previously, Cannon et al. found that 5-HTT levels were increased in thalamus, striatum, insular and cingulate cortices in unmedicated, depressed subjects with major depressive disorder[@R2] or bipolar disorder[@R3]. To explore this potential biomarker for mood disorders, we undertook a proof-of-principle genome-wide association study.

5-HTT levels, measured as \[^11^C\]DASB binding potential (BP~ND~), were assessed in six brain regions-of-interest (ROIs). Healthy (n=22) and unmedicated participants diagnosed with bipolar disorder (n=16) or major depressive disorder (n=17), aged 18 to 48 years (Mean ± SD, 34 ± 9 yr) underwent PET scanning with \[^11^C\]DASB. Subject ascertainment, PET scanning, and analysis were described previously[@R2]-[@R3]. DNA was extracted from peripheral blood and genotyped on the Illumina Human-1 SNP array. Genotypes were called with BeadStudio v3.0. Data were filtered for minor allele frequencies \< 1%, missing genotype rates \> 8%, Hardy-Weinberg Equilibrium p-values \<0.05, gender mismatch, and hidden relatedness. A total of 93,427 SNPs passed all quality control filters for all of the ROIs tested. Association analysis was performed by linear regression in PLINK[@R4] (v1.02), with 3 covariates to control for ancestry. Genomic Control lambda values were all \<1.05, indicating good control of confounding factors

Overall, 5 SNPs representing 5 different genes met our FDR\<0.1 criterion for being declared of interest: rs6741892 in *GALM*, rs390704 near *FRY*, rs7161217 near *TTLL5*, rs583241 near *CPLX4*, and rs7095106 near *CASC2*. The strongest association was between thalamic \[^11^C\]DASB-BP~ND~ and a coding SNP in the gene *GALM* (rs6741892, p=4.67×10^−8^; FDR=0.004). This result meets the threshold of genome-wide significance under typical frequentist assumptions, but not if corrected for 6 ROIs. rs6741892 accounted for about 50% of the variance in \[^11^C\]DASB-BP~ND~ in thalamus. Carriers of the "TT" genotype showed the highest \[^11^C\]DASB-BP~ND~.

Since the T-allele frequency differed by self-reported ancestry (10/13 in African-Americans, 3/13 in whites, and 0/7 in Hispanics), we also performed the analysis within each ancestry group, then combined the p-values by meta-analysis (META 5.3, <http://userpage.fuberlin.de/~health/meta_e.htm>), with similar results. We further confirmed this finding in a voxel-based analysis ([Fig 1](#F1){ref-type="fig"}).

Nominally-significant associations were also observed between rs6741892 and \[^11^C\]DASB-BP~ND~ in dorsal cingulate cortex (DCC; p=4.03×10^−2^) and insula (p=1.14×10^−3^). No SNPs near the gene encoding the 5-HTT (SLC6A4) showed significant association in this sample, consistent with one prior study[@R5], but we may have missed a true association due to lack of power. Rs6741892 was also individually genotyped using a modification of the 5′ nuclease (Taqman) assay, with similar results.

Consistent with our prior findings[@R2]-[@R3], we found a significant main effect of diagnosis on \[^11^C\]DASB-BP~ND~ measured in thalamus (F (2, 52) =7.07, p\<0.002) due to significantly higher thalamic \[^11^C\]DASB-BP~ND~ in participants with mood disorders. However, the overall association results were not dependent on diagnosis: rs6741892 was also associated with \[^11^C\]DASB-BP~ND~ in healthy participants.

Supportive evidence of association with rs6741892 was obtained from an independent replication sample of 51 European-ancestry subjects (16 females aged 43±20 yr, 35 males aged 34±18 yr) ascertained in Denmark, using TaqMan. Imaging and analysis were as described[@R6]. Significant associations were observed between rs6741892 and \[^11^C\]DASB-BP~ND~ in DCC (p=3.5×10^−3^) and insula (p=4.9×10^−3^), but not in thalamus, although \[^11^C\]DASB-BP~ND~ is highly correlated across subcortical structures[@R7]. Combined analysis with META 5.3 supported association between rs6741892 and \[^11^C\]DASB-BP~ND~ in all 3 regions of interest (DCC, p=9.18×10^−4^; insula, p=3.25×10^−5^; and thalamus, p=4.6×10^−6^).

*GALM* encodes galactose mutarotase, which catalyzes the conversion of beta-D-galactose to alpha-D-galactose[@R8], important in carbohydrate metabolism and the production of complex oligosaccharides. Galactose mutarotase might affect regional neurophysiology, leading to local increases in serotonin release and in membrane trafficking of 5-HTT[@R9], thereby increasing \[^11^C\]DASB-BP~ND~. Galactose mutarotase may also play a role in N-glycosylation, which is important for surface expression of 5-HTT[@R10].

To our knowledge, this is the first genome-wide association study of brain 5-HTT. These preliminary results suggest that neuroimaging phenotypes could represent informative targets for a GWAS, even in relatively small samples. Further studies are needed to confirm these findings and determine the underlying biological mechanisms.
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